DIACRIN INC /DE/
10-Q, EX-27, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: DIACRIN INC /DE/, 10-Q, 2000-08-11
Next: COMMUNITY INVESTMENT PARTNERS II LP, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>           5
<MULTIPLIER>        1
<CURRENCY>          U.S. DOLLARS

<S>                                <C>
<PERIOD-TYPE>                      6-MOS
<FISCAL-YEAR-END>                  DEC-31-2000
<PERIOD-START>                     JAN-01-2000
<PERIOD-END>                       JUN-30-2000
<EXCHANGE-RATE>                    1
<CASH>                             26,454,464
<SECURITIES>                       13,075,045
<RECEIVABLES>                      0
<ALLOWANCES>                       0
<INVENTORY>                        0
<CURRENT-ASSETS>                   39,988,097
<PP&E>                             2,029,301
<DEPRECIATION>                     1,543,739
<TOTAL-ASSETS>                     56,873,511
<CURRENT-LIABILITIES>              1,464,109
<BONDS>                            184,167
<COMMON>                           179,087
              0
                        0
<OTHER-SE>                         55,046,148
<TOTAL-LIABILITY-AND-EQUITY>       56,873,511
<SALES>                            0
<TOTAL-REVENUES>                   1,042,626
<CGS>                              0
<TOTAL-COSTS>                      0
<OTHER-EXPENSES>                   2,943,461
<LOSS-PROVISION>                   0
<INTEREST-EXPENSE>                 16,697
<INCOME-PRETAX>                    (2,056,562)
<INCOME-TAX>                       0
<INCOME-CONTINUING>                0
<DISCONTINUED>                     0
<EXTRAORDINARY>                    0
<CHANGES>                          0
<NET-INCOME>                       (2,056,562)
<EPS-BASIC>                      (.13)
<EPS-DILUTED>                      (.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission